Patents Assigned to Tulane University
  • Patent number: 11846629
    Abstract: The invention provides monocytes expressing CD16 and CD163 and experimental system for drug screening or evaluating drug candidates where the modulation of CD16 and CD163 is desired.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: December 19, 2023
    Assignee: Tulane University
    Inventors: Jay Rappaport, Sarah Vakili
  • Publication number: 20230181728
    Abstract: The adjuvanted conjugate opioid vaccine described herein is a conjugate of a protein carrier and at least one opioid backbone component or hapten conjugated thereto, admixed with at least one adjuvant. Anti-opioid effects are demonstrated after administration of a vaccine made up of the CRM197 protein carrier linked to a FEN backbone, combined with adjuvants such as dmLT or LTA1.
    Type: Application
    Filed: May 25, 2021
    Publication date: June 15, 2023
    Applicants: University of Houston System, Tulane University
    Inventors: Colin N. Haile, Gregory Cuny, Elizabeth B. Norton, Therese Kosten
  • Publication number: 20140234332
    Abstract: The invention provides a novel strain of HIV-2 capable of causing immunodeficiency. The invention also provides compositions comprising the nucleic acids and polypeptides characteristic of this HIV-2 virus, antibodies specific for this HIV-2 virus, methods of using these compositions, and methods of detecting HIV-2 virus.
    Type: Application
    Filed: April 28, 2014
    Publication date: August 21, 2014
    Applicant: Tulane University Health and Sciences Center
    Inventors: Stephen M. Smith, Preston A. Marx, JR.
  • Patent number: 8747862
    Abstract: The claimed invention is directed toward an HIV-2 isolate designated NWK08F, including variants, and isolated proteins and nucleotides obtained from said isolates.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: June 10, 2014
    Assignee: Tulane University Health Sciences Center
    Inventors: Stephen M. Smith, Preston A. Marx
  • Publication number: 20120027729
    Abstract: Transplantation of multipotent stromal cells (MSCs) into diabetic mice lowers blood sugar, increases blood insulin levels, increases the number and size of islets, and improves renal pathology. Accordingly, the invention provides methods for treating or preventing diabetes by administering isolated MSCs. The invention also provides methods for treating or preventing complications which arise from diabetes, including diabetic nephropathy, by transplanting isolated MSCs.
    Type: Application
    Filed: April 27, 2007
    Publication date: February 2, 2012
    Applicant: Tulane University Health Sciences Center
    Inventors: Darwin J. Prockop, Ryang Hwa Lee, Min Jeong Seo
  • Publication number: 20120027844
    Abstract: Compounds and their syntheses are disclosed herein. Compositions and pharmaceutical compositions comprising a compound are also described, and include compositions also comprising liposomes. Methods for the treatment of cancer in animals comprising administering a compound or a composition comprising a compound are also described.
    Type: Application
    Filed: February 9, 2010
    Publication date: February 2, 2012
    Applicants: XAVIER UNIVERSITY OF LOUISIANA, TULANE UNIVERSITY
    Inventors: Barbara S. Beckman, Maryam Foroozesh, Jiawang Liu
  • Patent number: 7892515
    Abstract: Carbon with mesopores (about two to fifteen nanometers in average pore size) is made using sucrose as a source of carbon, and silica and phosphoric acid as templates for the mesopore structure in the carbon. A silica sol is prepared in a water/ethanol medium and sucrose is dispersed in the sol. Phosphoric acid may be added to the sol to control pore size in the mesopore size range. The sol is dried, carbonized, and the silica and phosphate materials removed by leaching. The residue is a mesoporous carbon mass having utility as a catalyst support, gas absorbent, and the like.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: February 22, 2011
    Assignees: GM Global Technolgy Operations LLC, Tulane University; Administrators of the Tulane Education Fund
    Inventors: Qingyuan Hu, Yunfeng Lu, Jing Tang, Mei Cai
  • Patent number: 7824646
    Abstract: Mesoporous carbon and silica containing composites are prepared based on the co-assembly of a suitable surfactant in a liquid medium. When a low molecular weight carbonizable polymer and a silica precursor are added to the surfactant solution, a mixture of distinct phases of the materials is formed after solvent evaporation. A polymer/silica solid composite with highly organized mesopores is obtained after surfactant removal. This product has utility as a catalyst support or gas absorbent. And the polymer-silica composite can be easily converted successively to a mesoporous carbon-silica composite and to a bimodal mesoporous carbon material.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: November 2, 2010
    Assignees: GM Global Technology Operations, Inc., Tulane University
    Inventors: Mei Cai, Qingyuan Hu, Yunfeng Lu, Jing Tang
  • Publication number: 20100021366
    Abstract: Carbon with mesopores (about two to fifteen nanometers in average pore size) is made using sucrose as a source of carbon, and silica and phosphoric acid as templates for the mesopore structure in the carbon. A silica sol is prepared in a water/ethanol medium and sucrose is dispersed in the sol. Phosphoric acid may be added to the sol to control pore size in the mesopore size range. The sol is dried, carbonized, and the silica and phosphate materials removed by leaching. The residue is a mesoporous carbon mass having utility as a catalyst support, gas absorbent, and the like.
    Type: Application
    Filed: May 24, 2007
    Publication date: January 28, 2010
    Applicants: GM GLOBAL TECHNOLOGY OPERATIONS, INC. @@ TULANE UNIVERSITY, TULANE UNIVERSITY ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
    Inventors: Qingyuan Hu, Yunfeng Lu, Jing Tang, Mei Cai
  • Patent number: 7485460
    Abstract: The present invention encompasses methods and compositions for enhancing the growth of adult marrow stromal cells.
    Type: Grant
    Filed: May 21, 2003
    Date of Patent: February 3, 2009
    Assignee: Tulane University Health Sciences Center
    Inventors: Darwin Prockop, Ichiro Sekiya, Carl Gregory, Jeffrey Spees, Jason Smith, Radhika Pochampally
  • Publication number: 20080299097
    Abstract: Multipotent stromal cells “MSCs” have been described as consisting of at least two populations of cells, rapidly self-renewing stem cells (RS-MSCs), and larger, slowly replicating cells (mMSCs). The present invention provides methods for enhancing engraftment of MSCs in vivo by administering an enriched fraction of RS-MSCs that express certain cell surface markers.
    Type: Application
    Filed: November 8, 2007
    Publication date: December 4, 2008
    Applicant: Tulane University Health Sciences Center
    Inventors: Darwin J. Prockop, Ryang Hwa Lee
  • Patent number: 7361493
    Abstract: Embodiments of a method for the production of human urokinase are disclosed. Also disclosed are embodiments of a cell culture well-suited for use with the disclosed method. The method involves culturing urokinase-producing cells, such as immortalized human renal cells, in a cell culture. The cell culture comprises microcarrier structures and a tissue culture medium. The urokinase production is allowed to occur while the cell culture remains relatively static, i.e., the cell culture is not substantially mixed.
    Type: Grant
    Filed: May 26, 2005
    Date of Patent: April 22, 2008
    Assignees: The United States of America as represented by the Secretary of the Department of Veterans Affairs, Tulane University
    Inventors: Timothy G. Hammond, Patricia L. Allen
  • Publication number: 20080087314
    Abstract: A thermoelectric material comprises core-shell particles having a core formed from a core material and a shell formed from a shell material. In representative examples, the shell material is a material showing an appreciable thermoelectric effect in bulk. The core material preferably has a lower thermal conductivity than the shell material. In representative examples, the core material is an inorganic oxide such as silica or alumina, and the shell material is a chalcogenide semiconductor such as a telluride, for example bismuth telluride. A thermoelectric material including such core-shell particles may have an improved thermoelectric figure of merit compared with a bulk sample of the shell material alone. Embodiments of the invention further include thermoelectric devices using such thermoelectric materials, and preparation techniques.
    Type: Application
    Filed: October 13, 2006
    Publication date: April 17, 2008
    Applicants: Tulane University, Toyota Engineering & Manufacturing North America, Inc.
    Inventors: Qiangfeng Xiao, Yunfeng Lu, Junwei Wang, Minjuan Zhang
  • Publication number: 20080039580
    Abstract: Mesoporous carbon and silica containing composites are prepared based on the co-assembly of a suitable surfactant in a liquid medium. When a low molecular weight carbonizable polymer and a silica precursor are added to the surfactant solution, a mixture of distinct phases of the materials is formed after solvent evaporation. A polymer/silica solid composite with highly organized mesopores is obtained after surfactant removal. This product has utility as a catalyst support or gas absorbent. And the polymer-silica composite can be easily converted successively to a mesoporous carbon-silica composite and to a bimodal mesoporous carbon material.
    Type: Application
    Filed: May 24, 2007
    Publication date: February 14, 2008
    Applicants: GM GLOBAL TECHNOLOGY OPERATIONS, INC. @ @ TULANE UNIVERSITY, TULANE UNIVERSITY ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
    Inventors: Mei Cai, Qingyuan Hu, Yunfeng Lu, Jing Tang
  • Patent number: 7056738
    Abstract: Marrow stromal cells (MSCS) are adult stem cells from bone marrow that can differentiate into multiple non-hematopoietic cell lineages. Colonies of human MSCs were shown to contain both small, rapidly self-renewing stem cells (RS cells) and large, more mature cells (mMSCs). Samples enriched for RS cells had a greater potential for multipotential differentiation than samples enriched for mMSCs. Also, RS cells have a series of surface epitopes and expressed proteins that can be used to differentiate RS cells from mMSCs. The results suggest that it will be important to distinguish the two major sub-populations of MSCs in defining their biology and their potentials for cell and gene therapy.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: June 6, 2006
    Assignees: Tulane University, Philadelphia Heath and Education Corporation
    Inventors: Darwin J. Prockop, David C. Colter, Ichiro Sekiya
  • Patent number: 6465613
    Abstract: The invention features novel somatostatin analogs that may be readily labeled with toxic or non-toxic detectable labels. These unlabeled and labeled analogs are useful for specifically targeting somatostatin receptor bearing cells, in particular neoplastic cells. Labeled analogs are useful, for example, for tumor localization and detection. Where labeled with a toxic label (e.g., radioactivity), the analogs are useful for the targeted delivery of toxicity to somatostatin receptor-bearing cells, in particular neoplastic cells. Also disclosed are methods for treating and detecting neoplasms, and methods for imaging somatostatin receptor-bearing cells.
    Type: Grant
    Filed: November 19, 1998
    Date of Patent: October 15, 2002
    Assignee: Tulane University
    Inventors: David H. Coy, William A. Murphy, Eugene A. Woltering, Joseph A. Fuselier, George Drouant
  • Patent number: 6251611
    Abstract: A method of determining the presence of chronic volume dependent hypertension is provided wherein a determination is made as to whether there has been a substantial reduction in phosphorylation of the blood-derived protein or renal proximal brush border membrane protein and if such reduction exists concluding that chronic volume dependent hypertension exists in a patient. The method may advantageously be practiced by employing blood serum or blood plasma as the body specimen containing the protein in determining whether a patient has chronic volume dependent hypertension, a cellular component of the blood, such as a blood-derived protein coming from the plasma membrane of lymphocytes. The method may include subsequent therapeutic patient treatment. Related diagnostic apparatus is also provided.
    Type: Grant
    Filed: September 26, 1997
    Date of Patent: June 26, 2001
    Assignee: Tulane University Medical Center
    Inventor: Jules B. Puschett
  • Patent number: 5387378
    Abstract: The present invention provides a method for fabricating an asymmetric fluoropolymer membrane comprised of a fluoropolymer material, the membrane having a first surface comprised of a dense layer of the fluoropolymer material, and an opposite second surface comprised of a porous layer of the fluoropolymer material, comprising the steps of:(a) dissolving a fluoropolymer material in a solvent to form a solution;(b) depositing the solution on a casting surface; and(c) removing the solvent from the solution, thereby precipitating the membrane therefrom.The present invention also provides asymmetric fluoropolymer membranes comprised of a fluoropolymer material, wherein the membrane has a first surface comprised of a dense layer of the fluoropolymer material, and an opposite second surface comprised of a porous layer of the fluoropolymer material, and provides compositions for making the same.
    Type: Grant
    Filed: April 21, 1993
    Date of Patent: February 7, 1995
    Assignee: Tulane University
    Inventors: Peter N. Pintauro, Kangzhuang Jian
  • Patent number: 5004476
    Abstract: Hip joint prosthesis for replacing diseased or defective joints including a femoral stem, vacuum cast of cobalt-chromium-molybdenum and hot isostatically pressed (HIP'd) both before and after porous coating to provide an additional 50% greater strength in high cycle fatigue loading than all comparable porous coated devices of prior art, with optimal porous coating parameters scientifically and clinically determined for 75% greater fixation than all comparable devices of prior art, anatomically shaped and easily constructed in right and left configurations and a range of sizes, a femoral head which attaches to the stem intraoperatively, and an acetabular component consisting of a polymer bearing-type insert mechanically fixed inside a metal shell, the bearing surface articulating with the femoral head.
    Type: Grant
    Filed: October 31, 1989
    Date of Patent: April 2, 1991
    Assignee: Tulane University
    Inventor: Stephen D. Cook